Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

XCUR Insider Trading

EXICURE, INC. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at EXICURE, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-01-21 20:46 2026-01-21 Exicure HiTron Inc. 10% owner SELL $4.50 258,367 $1,162,652 1,598,947 -13.9%
2026-01-20 22:09 2026-01-16 Exicure HiTron Inc. 10% owner SELL $4.50 734,747 $3,306,362 1,857,314 -28.3%
2026-01-09 04:42 2026-01-07 Exicure HiTron Inc. 10% owner SELL $4.50 741,272 $3,335,724 2,592,061 -22.2%
2025-12-11 04:51 2025-12-08 SANGSANGIN INVESTMENT & SECURITIES CO., LTD. 10% owner SELL $8.71 433,332 $3,774,322 0 -100.0%
2025-03-27 00:41 2024-12-26 HiTron Systems Inc. 10% owner BUY $3.00 2,900,000 $8,700,000 3,333,333 +669.2%
2024-09-17 04:41 2024-09-12 DGP Co., Ltd. 10% owner BUY $3.00 237,223 $711,669 849,223 +38.8%
2024-03-05 02:36 2024-02-29 DGP Co., Ltd. 10% owner SELL $1.32 3,400,000 $4,488,000 0 -100.0%
2022-12-20 00:54 2022-12-15 CBI USA, Inc. 10% owner BUY $1.60 3,400,000 $5,440,000 4,218,299 +415.5%
2022-05-19 23:50 2022-05-19 Muralidhar Bali Director BUY $0.19 1,472,126 $285,151 8,449,126 +21.1%
2021-12-23 00:13 2021-12-21 Gates Frontier, LLC 10% owner SELL $0.24 1,268,619 $303,200 5,064,703 -20.0%
2021-09-08 14:00 2021-08-27 Papadimas Elias D. Officer - Chief Accounting Officer BUY $1.38 10,000 $13,800 10,000 +100.0%
2020-06-17 04:43 2020-06-12 AURASENSE LLC 10% owner SELL $2.83 10,195 $28,852 11,257,629 -0.1%
2020-06-17 04:35 2020-06-12 Mirkin Chad A. Director, 10% owner SELL $2.83 10,195 $28,852 11,257,629 -0.1%
2020-03-16 15:46 2020-03-12 Mirkin Chad A. Director, 10% owner BUY $1.45 15,000 $21,750 15,000 +100.0%
2020-03-16 15:46 2020-03-12 SNYDER DAVID S Officer - Chief Financial Officer BUY $1.40 18,248 $25,591 18,248 +100.0%
2020-03-16 15:47 2020-03-13 WALT DAVID R Director BUY $1.21 291,066 $352,859 2,058,777 +16.5%
2019-12-24 00:05 2019-12-19 Muralidhar Bali Director BUY $2.75 727,000 $1,999,250 6,977,000 +11.6%
2019-08-07 00:13 2019-08-02 Mirkin Chad A. Director, 10% owner BUY $2.00 25,000 $50,000 25,000 +100.0%
2019-08-07 00:11 2019-08-02 Venkatesan Jay Director BUY $2.00 250,000 $500,000 302,234 +478.6%
2019-08-07 00:09 2019-08-02 WALT DAVID R Director BUY $2.00 1,000,000 $2,000,000 1,767,711 +130.3%
2019-03-22 23:12 2019-03-22 Mirkin Chad A. Director, 10% owner BUY $2.30 500 $1,150 27,267 +1.9%
2019-03-21 23:41 2019-03-21 Mirkin Chad A. Director, 10% owner BUY $2.43 1,000 $2,430 26,767 +3.9%
2019-03-19 23:52 2019-03-19 Giljohann David A Director, Officer - Chief Executive Officer BUY $2.40 7,000 $16,800 23,666 +42.0%
2019-03-19 00:21 2019-03-18 Mirkin Chad A. Director, 10% owner BUY $2.40 1,000 $2,400 25,767 +4.0%
2019-03-14 23:58 2019-03-13 Mirkin Chad A. Director, 10% owner BUY $2.50 2,200 $5,500 24,767 +9.7%
2017-09-29 04:42 2017-09-26 Giljohann David A Director, Officer - Chief Executive Officer BUY $3.00 16,666 $49,998 16,666 +100.0%
2017-09-29 04:40 2017-09-26 Venkatesan Jay Director BUY $3.00 66,666 $199,998 156,858 +73.9%
2017-09-29 04:43 2017-09-26 WALT DAVID R Director BUY $3.00 268,333 $804,999 767,711 +53.7%
SHOW ENTRIES

How to Interpret $XCUR Trades

Not every insider transaction in EXICURE, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $XCUR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for XCUR

Insider activity data for EXICURE, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $XCUR, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.